Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock Options (Tables)

Stock Options (Tables)

3 Months Ended

Jan. 31, 2014

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Options Outstanding
			Weighted Average
	Number of Shares		Exercise Price
Balance, October 31, 2012	1,700,000	$	0.26
Granted	500,000		0.10
Balance, January 31, 2014 and October 31, 2013	2,200,000	$	0.23

Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

January 31, 2014		Options outstanding		Options exercisable

Range of Exercise	Number of	Weighted average	Weighted average	Number of	Weighted average
prices	shares	remaining contractual life	exercise price	shares	exercise price
$0.20	150,000	1.54 years	$0.20	150,000	$0.20
$0.20	850,000	0.97 years	$0.20	850,000	$0.20
$0.35	700,000	2.45years	$0.35	700,000	$0.35
$0.10	500,000	4.38 years	$0.20	500,000	$0.10
Total	2,200,000	2.25 years	$0.23	2,200,000	$0.23

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References + Details